Diffuse Large B-Cell Lymphoma — A Grand Rounds Program

Featuring a presentation by Dr Matthew Matasar, including the following topics:

• Selection of First-Line Therapy for Patients with Diffuse Large B-Cell Lymphoma (DLBCL) (0:00)
• Clinician Survey Results Regarding First-Line Treatment of DLBCL (11:41)
• Current and Future Roles of Monoclonal and Bispecific Antibodies in Therapy for Relapsed/Refractory (R/R) DLBCL (16:01)
• Clinician Survey Results Regarding the Use of Monoclonal and Bispecific Antibodies for R/R DLBCL (28:47)
• Evidence-Based Incorporation of Antibody-Drug Conjugates (ADCs) into the Management of R/R DLBCL (34:34)
• Clinician Survey Results Regarding the Use of ADCs for R/R DLBCL (46:31)
• Discussion of Questions from the Community (50:20)

CME information and select publications